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ABSTRACT We have generated an anti-peptide antibody
specific for the class A calcium channel a, subunit from rat
brain. In immunoblots of the calcium channel complex par-
tialy purified from rat brain membranes, the antibody spe-
cifically recognized two doublets, one of apparent Mr 210,000
and Mr 180,000 and another of apparent Mr 160,000 and Mr
130,000. Immunofluorescent staining of sections of rat dia-
phragm showed that this antibody specifically recognizes an-
tigens that are highly concentrated at neuromuscular synapses.
Using this antibody, we also examined the distribution of the
class A a, subunit in sttal sections of rat cerebellum by
immunoperoxidase staining. Specific immunoreactivit was
localized in the granule cell layer, possibly to the cerebellar
glomeruli, the unique structures in cerebellum where mossy
fibers synapse with granule cell dendrites. Purkinje cell neu-
rons were not stained specifically. These results indicate that
the class A calcium channel a, subunit is highly concentrated
at mammalian neuromuscular junction and has a restricted
localization in cerebellum that does not include Purkinje cell
soma or dendrites.
Voltage-dependent calcium channels mediate the entry of
calcium into cells in response to changes in membrane
potential. During synaptic transmission, calcium influx
through voltage-dependent calcium channels in the presyn-
aptic membrane results in a local transient increase in cal-
cium concentration. By a mechanism that is not completely
understood, this increase in calcium concentration is coupled
to secretion of neurotransmitter into the synaptic cleft (1-3).
Multiple classes of voltage-dependent calcium channels
have been identified on the basis of electrophysiological and
pharmacological properties and are called T-, L-, N-, and
P-type, and doe-1 (4-7). Of these, L, N, and P are high
voltage-activated calcium channels. The L-type dihydropyr-
idine-sensitive calcium channel, which has been best char-
acterized biochemically, is most abundant in skeletal muscle,
where it is preferentially localized to the transverse tubule
membrane. The L-type calcium channel purified from this
source is a complex of five subunits called al (Mr 170,000),
a2 (Mr 143,000), 8 (Mr 55,000), y (Mr 30,000), and 8 (Mr
27,000) (8-10). The central transmembrane al subunit con-
tains the voltage sensor, pore, and binding sites for calcium
channel agonists and antagonists. Therefore, the a, subunit
is responsible for voltage gating, calcium conductance, and
sensitivity to pharmacological agents and can function alone
when expressed in Xenopus oocytes (11) or mammalian cells
(12). This subunit has four homologous domains (I, II, III,
and IV), each having six predicted a-helical transmembrane
segments (S1 through S6). Cloning and sequencing of differ-
ent calcium channel al subunit types has revealed that, while
the proposed transmembrane segments are highly conserved,
the intracellular loop between domains II and III and the
intracellular carboxyl-terminal region are highly variable
(13).
The known primary structures ofneuronal calcium channel
al subunits fall into five classes named A, B, C, D, and E (14,
15). These classes may be grouped into two subfamilies based
on sequence homology. One subfamily encodes L-type cal-
cium channel al subunits and includes class C transcripts
(which are expressed in heart, smooth muscle, and brain) and
class D transcripts (which are expressed in brain and endo-
crine cells). The other subfamily includes class A, class B,
and class E transcripts, which are almost exclusively ex-
pressed in neurons. The class B transcript encodes an al
subunit that is part of the N-type w-conotoxin GVIA-
sensitive calcium channel. However, the functional classifi-
cations of the class A and class E transcripts have not been
definitively established (6). It has been widely assumed that
the class A transcript encodes the al subunit of the P-type
w-agatoxin IVA (co-Aga-IVA)-sensitive calcium channel orig-
inally described in cerebellar Purkinje cells (16-18). The class
E transcript from rat brain encodes an unusual low-voltage-
activated channel that is distinct from the T-type low-voltage-
activated channel described in cardiac cells, sensory neu-
rons, and endocrine cells (15).
At the frog neuromuscular junction, fluorescently tagged
w-conotoxin GVIA labels presynaptic nerve terminals, and
w-conotoxin GVIA irreversibly blocks synaptic transmis-
sion, identifying the presynaptic calcium channel as N-type
(19, 20). Neither w-conotoxin GVIA nor dihydropyridines
block neuromuscular transmission in mammals, however (21,
22). It has been reported that funnel web toxin (FTX), which
is a low molecular weight polyamine fraction from funnel-
web spider venom (23), and w-Aga-IVA (24)-both P-type
calcium channel blockers-inhibit release of neurotrans-
mitter at the mouse neuromuscular junction. To address the
question of which calcium channel type is present at this
synapse in mammals, we have generated an antiserum in
rabbit against a peptide that corresponds to a sequence within
the class A calcium channel al subunit from rat brain (25).
The anti-peptide antibody purified from this antiserum was
used in immunocytochemical studies of rat diaphragm and of
cerebellum, where Purkinje neurons express P-type calcium
channels.
MATERIALS AND METHODS
Materials. Peptide 1 [ERKRRHRHGPPAHDDRERR in
single-letter amino acid code; corresponds to amino acids
965-983 of the rbA clone (25)] and an irrelevant peptide
[RQTARPRESARDPDARRA; corresponds to amino acids
Abbreviations: w-Aga-IVA, w.agatoxin-IVA; RAb 2103, affinity-
purified rabbit antibody to calcium channel peptide; KLH, keyhole
limpet hemocyanin; PBS, phosphate-buffered saline; FTX, funnel
web toxin.
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846-863 of the rbA clone (25)] were synthesized by Macro-
molecular Resources (Fort Collins, CO). Peptides 2 [HGP-
PAHDDRERR; corresponds to amino acids 972-983 of the
rbA clone (25)] and 3 [ERRARHRGP; corresponds to amino
acids 959-967 of the rbB-1 clone (26)] were synthesized by
the peptide synthesis facility at the University of North
Carolina (Chapel Hill). The Bodipy FL-conjugated a-bunga-
rotoxin was obtained from Molecular Probes. Normal sera
and all other antibodies were purchased from Jackson Im-
munoResearch. Sequence alignment was performed with
Lasergene computer software from DNAstar (Madison, WI).
Conjugation of Peptide and Production of Antisera. Peptide
1 was coupled through sulfhydryl groups to keyhole limpet
hemocyanin (KLH) with sulfo-m-maleimido benzoyl-N-
hydroxy succinimide ester (sulfo-MBS) (27). KLH-
conjugated peptide (1 mg) was emulsified with an equal
volume of complete Freund's adjuvant and injected intrader-
mally into 15-20 sites on the back oftwo female New Zealand
White rabbits. Rabbits were subsequently administered
boosters at 3-week intervals by subcutaneous injection of 0.1
mg of KLH-conjugated peptide emulsified with an equal
volume of incomplete Freund's adjuvant (28). Antibodies
were affinity-purified from whole serum by standard methods
using Affi-Gel 10-coupled peptide 1.
Isolation of Calcium Channels and Immunoblotting. Prep-
aration of membrane fractions from rat brain and subsequent
solubilization and partial purification of calcium channels
were done essentially as described by Westenbroek et al.
(29). After separation by SDS/PAGE (0.04% methylenebis-
acrylamide/8% acrylamide), proteins were transferred onto
Immobilon-P membrane by using the Trans-Blot semidry
method at 5 V for 0.8 hr in 25 mM Tris/192 mM glycine buffer
(Bio-Rad). The blots were blocked by incubation for 1 hr in
TBST (150 mM NaCl/10 mM Tris, pH 8.0/0.05% Tween 20)
containing 0.1% fish gelatin and then were incubated over-
night with 5.4 nM affinity-purified rabbit anti-peptide anti-
body (RAb 2103). The blots were washed, incubated for 1 hr
with horseradish peroxidase-linked anti-rabbit IgG diluted
1:5000, washed with TBST alone, and developed with the
enhanced chemiluminescence (ECL) reagent (Amersham).
Immunofluorescence Studies ofRat Diaphragm. Strips ofrat
diaphragm were rolled up and frozen in isopentane in liquid
nitrogen. Transverse sections (6 ,um) were stained for cho-
linesterase activity (30) to identify a region of the tissue block
containing motor end plates. Sections containing end plates
were incubated in blocking buffer [1% fish gelatin/0.08%
bovine serum albumin/0.02% sodium azide in phosphate-
buffered saline (PBS; 137 mM NaCl/2.7 mM KC1/4.3 mM
Na2HPO4 7 H20/1.4 mM KH2PO4), pH 7.3] for 5 min and
then incubated with 27 nM Rab 2103 in blocking buffer for 1
hr at room temperature. To show peptide inhibition of
staining in some sections, Rab 2103 was preincubated with
relevant or irrelevant peptide for 1 hr. After the sections were
rinsed in PBS for 15 min, sections were incubated in blocking
buffer containing Bodipy FL-conjugated a-bungarotoxin at 1
Mg/ml, Lissamine rhodamine-conjugated donkey anti-rabbit
IgG at 1.5 ug/ml, and rat serum at 20 ug/ml for 1 hr at room
temperature. After the sections were rinsed in PBS for 15
min, sections were fixed in 4% paraformaldehyde for 5 min
and mounted in glycerol containing n-propyl gallate (5.7 g of
glycerol/0.25 g of n-propyl gallate/0.5 ml of 2x PBS) to
reduce bleaching.
Immunocytochemistry of Cerebellum. Adult rats were per-
fused with 4% paraformaldehyde in 0.1 M sodium phosphate
(pH 7.4). The brains were removed, postfixed in the same
solution for several days, and cryoprotected by allowing the
brains to sink first in 0.1 M sodium phosphate, pH 7.4/4%o
paraformaldehyde and then in 0.1 M sodium phosphate, pH
7.4/30% sucrose. Brains were frozen in isopentane in liquid
nitrogen. Free-floating sagittal sections (40 pum) through
cerebellum were stained with 27 nM RAb 2103 by the
Vectastain ABC method (Vector Laboratories). To show
peptide inhibition of staining in some sections, Rab 2103 was
preincubated with relevant or irrelevant peptide for 1 hr.
Some sections were counterstained with cresyl violet.
RESULTS
An antibody was made against a peptide (peptide 1; see Fig.
1) predicted from the nucleotide sequence of the class A
calcium channel al subunit transcript from rat brain (25) and
was affinity-purified by using peptide 1. This peptide is found
within the highly variable intracellular loop between domains
II and III of the a, subunit. The skeletal muscle L-type a,
subunit and the neuronal L-type class C and class D se-
quences, which have short intracellular loops between do-
mains II and III, do not have a homologous sequence (16, 31).
Furthermore, there is no homology between the class A
peptide and the class E al subunit sequence (31). However,
part of the class A peptide is homologous to the class B al
subunit sequence. Alignment of the class A peptide with the
homologous sequence in the class B al subunit is shown in
Fig. 1 (25, 26). To demonstrate by peptide inhibition that our
antibody does not recognize epitopes that are found in the
class B sequence, we made two smaller peptides (shown in
Fig. 1). One is unique to the class A al subunit (peptide 2),
and the other corresponds to the region of the class B
sequence that is homologous to part of the class A peptide
(peptide 3).
We isolated a glycoprotein fraction from rat brain by a
method that has been used to partially purify calcium channel
complexes (29). In immunoblots ofthis glycoprotein fraction,
our affinity-purified antibody consistently recognized two
doublets, one of apparent Mr 210,000 and M, 180,000 and
another of apparent Mr 160,000 and Mr 130,000 (Fig. 2).
Normal rabbit IgG did not recognize these four protein bands
(data not shown). The specificity of this interaction was
tested by inhibition with relevant peptide 2. After preincu-
bation of our affinity-purified antibody with peptide 2 (5.4
AM), the signal in immunoblots was dramatically reduced for
all four protein bands as shown in Fig. 2. Therefore, our
affinity-purified antibody predominantly recognizes epitopes
unique to the class A al subunit. The signal was not com-
pletely eliminated by peptide 2, indicating that our antibody
includes some IgGs that recognize epitopes found in peptide
1, but not in peptide 2, or epitopes that bridge the boundary
(see Fig. 1).
ClassA a, Subunit Is Present at Mammalian Neuromuscular
Junction. Sections ofrat diaphragm were labeled with Bodipy
FL-conjugated a-bungarotoxin to locate neuromuscular syn-
apses and were double-labeled with our affinity-purified
antibody followed by a Lissamine rhodamine-conjugated
secondary antibody to determine the distribution of the class
A al subunit in innervated skeletal muscle. Synapses on the
muscle fibers were intensely labeled with our antibody (Fig.
3 A and B). Intense antibody staining was restricted to the
synaptic region and very closely matched the a-bungarotoxin
staining, which identifies acetylcholine receptors in the
classA E R K R R H R H G P P A H D D R E R R peptide I
class B E R R A R H R - G P R E T E N S E E P
H G P P A H D D R E R R peptide 2
E R R A R H R - G P peptide 3
FIG. 1. Alignment of the class A peptide (peptide 1) with a
homologous amino acid sequence in the class B al subunit. Peptide
2 is unique to the class A al subunit. Peptide 3 corresponds to a region
in the class B al subunit that is homologous to part of the class A
peptide.






























FIG. 2. Immunoblots of a calcium channel preparation from rat
brain were incubated with RAb 2103 without Oane A) or with (lane
B) prior incubation with peptide 2. The position of molecular weight
markers x 10-3 are indicated.
postsynaptic membrane. Preincubation of the antibody with
the relevant peptide 1 completely eliminated synaptic stain-
ing (Fig. 3 C and D), while an irrelevant peptide had no effect
on staining (Fig. 3 E and F). As expected, preincubation with
FIG. 3. Immunofluorescence images of rat diaphragm muscle.
Sections were incubated with RAb 2103 (27 nM) without (A and B)
or with prior incubation with peptide 1 (C and D) or an irrelevant
peptide (E and F). Sections were then incubated with Bodipy
FL-conjugated a-bungarotoxin and Lissamine rhodamine-conju-
gated secondary antibody. The same field was photographed under
fluorescein (A, C, and E) or Lissamine rhodamine (B, D, and F)
optics.
the peptide that is unique to the class A al subunit (peptide
2) dramatically reduced, but did not completely eliminate,
synaptic staining (Fig. 4 C and D). The class B peptide
(peptide 3) did not compete for antibody binding (Fig. 4Eand
F), demonstrating that the antibody does not recognize
N-type calcium channels at mammalian neuromuscularjunc-
tion. This is consistent with evidence from other investigators
that the presynaptic calcium channel mediating neuromus-
cular transmission in mammals is not N-type (21, 22). Our
results indicate that the class A al subunit is present at the
mammalian neuromuscular junction.
Localzatlon of the Class A a, Subunit in Cerebeflr Cortex.
We determined the distribution ofantibody labeling in sagittal
sections ofrat cerebellum by the immunoperoxidase method.
The densest staining was observed in the granule cell layer as
a patchy pattern of immunoreactivity, and diffuse staining in
the molecular layer was also noted (Fig. SA). Preincubation
of antibody with the peptide unique to the class A al subunit
(peptide 2) eliminated this staining in the granule cell and
molecular layers (Fig. SB). Both an irrevelant peptide and the
class B peptide (peptide 3) failed to compete for antibody
binding (data not shown), indicating that the antibody stain-
ing at these sites in cerebellum is due to the class A a,
subunit. Normal rabbit IgG did not stain rat cerebellum (data
not shown). The light staining of Purkinje cell bodies, barely
visible in sections stained with antibody alone, and the
staining of a few Golgi cell bodies in the granule cell layer
were determined to be nonspecific, as staining was not
FIG. 4. Immunofluorescence images of rat diaphragm muscle.
Sections were incubated with 27 nM RAb 2103 without (A and B) or
with prior incubation ofRAb 2103 with peptide 2 (C andD) or peptide
3 (E and F). Sections were then incubated with Bodipy FL-
conjugated a-bungarotoxin and Lissamine rhodamine-conjugated
secondary antibody. The same field was photographed under fluo-
rescein (A, C, and E) or Lissamine rhodamine (B, D, and F) optics.
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corresponds to the spatial distribution of cerebellar glomer-
uli. Thus, immunoreactivity in the granule cell layer could
represent either presynaptic localization of the class A al









FIG. 5. Immunoreactivity in sagittal sections tI
belium. Sections were incubated with 27 nM RAb2
or with (B) prior incubation with peptide 2. (A) A p~
dense labeling in the granule cell layer (GCL) and di
the molecular layer (ML) were observed. (B) Both
by prior incubation of antibody with peptide, 2. Non
of Purkixije neurons in the Purkinje cell layer (PCL)
cells in the GCL was also noted. (C) A higher
the GCL in sections counterstained, with cresyl viol
bodies showed that the immunoreactivity and cel
colocalize.
blocked by preincubation of antibody with p
SB).
A higher magnification view of the granule
sections counter-stained with cresyl violet
bodies showed that the immunoreactivity and
the granule cell layer do not coincide (Fig. 5i
glomeruli, the unique structure in the granule ci
mossy fibers synapse with granule cell dendi
apparent clearings between granule cells (32).
tion of immunoreactivity we observe in the gra
I..:
We have demonstrated that an antipeptide antibody specific
for the class A calcium channel al subunit recognizes anti-
gens that are highly concentrated at the mammalian neuro-
muscular junction. Although the class A transcript predicts a
protein of Mr 252,000 (25) in immunoblots, our antibody
recognized brain glycoproteins of apparent Mr 210,000, Mr
180,000, Mr 160,000, and Mr 130,000. This is as expected
because the sizes of calcium channel a, subunits, as esti-
mated by mobility in SDS/PAGE gels, are typically smaller
than the sizes predicted by the nucleotide sequences of their
cDNAs (see ref. 33 for a discussion). The different molecular
weight forms recognized by our antibody may be the result of
alternative splicing of the class A a, subunit transcript at the
carboxyl-terminal region as has been noted for other classes
of a, subunits (33). Four cDNAs from rat brain (25) and two
cDNAs from rabbit brain (16) that encode the class A a,
subunit differing only in their carboxyl-terminal regions have
been identified. Alternatively, the different forms may be the
product of posttranslational processing, as is likely the case
for the skeletal muscle L-type a, subunit (33).
It has been difficult to characterize functionally the pre-
synaptic calcium channel that mediates neuromuscular trans-
mission in mammals, in part, because some calcium channel
antagonists that inhibit transmission at this synapse partially
overlap in their selectivities. It has been reported that the
P-type calcium channel mediates neuromuscular transmis-
sion in mouse based on the evidence that FTX reduces
quantal content of evoked neurotransmitter release (50%o
reduction at concentrations of FTX < 1 uM) (23). Further-
more, in a mouse hemidiaphragm preparation, wo-Aga-IVA
(17, 34) reduced the quantal content of the endplate potential
by 50%o at 20 nM (38). At 40 nM and 100 nM ai-Aga-IVA, the
quantal content was reduced by 80%o and 95%, respectively
(35). Although the concentrations used were greater than that
required for selective block of P-type channels in Purkinje
neurons, this is typical for nerve-muscle preparations (19-22,
36). Overall, the available pharmacological evidence sup-
ports the conclusion that P-type calcium channels, at least in
part, mediate neuromuscular transmission in mammals.
Although the class A a, subunit is often considered to be
part of the P-type w-Aga-IVA-sensitive calcium channel, this
hrough rat cere- has not been shown definitively. There is, however, indirect
2103 without (A) evidence suggesting that the class A a, subunit may be similar
atchy pattern of at the molecular level to the P-type calcium channel al
iffuse staining in subunit. The predominant calcium channels in Purkinje neu-
were eliminated rons, which are resistant to both dihydropyridines and
specific staining w-conotoxin but sensitive to FTX and P-Aga-IVA (17, 18,
icand a few Golgi 34), have been classified as P-type according to their phar-
let to reveal cell macology. The class A (Bi) al subunit transcript isolated
I
bodies do not from rabbit brain is expressed predominantly in the cerebel-
lum. Because the level of this transcript is reduced in the
cerebellum of several mouse mutants-in pcd mice (in which
)eptide 2 (Fig. Purkinje cells degenerate), in staggerer mice (in which Pur-
kinje cells have stunted dendrites), and in weaver mice
e cell layer in (which are deficient in granule cells)-it has been suggested
to reveal cell that this transcript is expressed in Purkinje neurons and
I cell bodies in granule cells (16) and may encode the a, subunit of the
C). Cerebellar predominant P-type calcium channel found in Purkinje neu-
ell layer where rons. Further evidence comes from expression of the class A
rites, occur at (Bi) transcript in Xenopus oocytes. The resulting calcium
. The distribu- current is insensitive to dihydropyridines and o-conotoxin
mule cell layer (16) but is blocked by co-Aga-IVA (37).
ML
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Our result-namely, that the class A al subunit has a very
restricted localization in cerebellum that may correspond to
synaptic sites within the cerebellar glomeruli but does not
include Purkinje cell soma and dendrites, where P-type
calcium channels are localized (24)-was surprising. How-
ever, there may exist mRNA transcripts that are distinct but
closely related to transcripts of the class A (Bi) al subunit.
This could be due to alternative splicing of the class A al
subunit transcript or to the expression ofa distinct but closely
related gene. Thus, there may exist heterogeneity ofthe class
A al subunit at the molecular level that has not been
previously recognized. We suggest that the class A al sub-
unit, which is highly concentrated at mammalian neuromus-
cular junction, may be part of a calcium channel complex
distinct from the P-type calcium channel expressed in Pur-
kinje cells.
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